Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1999 Oct;48(4):471-80.
doi: 10.1046/j.1365-2125.1999.00026.x.

Acetylcholinesterase inhibitors in Alzheimer's disease

B M McGleenon  1 , K B Dynan, A P Passmore
Affiliations
Review

Acetylcholinesterase inhibitors in Alzheimer's disease

B M McGleenon et al. Br J Clin Pharmacol. 1999 Oct.
No abstract available

PubMed Disclaimer

References

    1. Khann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34:939–944. - PubMed
    1. Katzman R, Saitoh T. Advances in Alzheimer’s Disease. FASEB J. 1991;5:278–286. - PubMed
    1. Becker RE. In: Cholinergic Basis of Alzheimer Therapy. Becker RE, Giacobini E, editors. Boston: Berkhauser; 1991. pp. 1–22. Therapy of the cognitive deficit in Alzheimer’s disease; the cholinergic system.
    1. Cutler NR, Sramek JJ, Veroff AE. Alzheimer’s Disease. Chichester: John Wiley and Sons; 1994.
    1. Becker RE, Giacobini E. Mechanisms of cholinesterase inhibition in senile dementia of the Alzheimer type; clinical pharmacological and therapeutic aspects. Drug Dev Res. 1988;12:163–195.

MeSH terms

Substances